# Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

> **NCT01302080** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 941 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** sertraline
- **BEHAVIORAL:** psychotherapy

## Key facts

- **NCT ID:** NCT01302080
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-04
- **Primary completion:** 2020-09-09
- **Final completion:** 2020-09-09
- **Target enrollment:** 941 (ACTUAL)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01302080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01302080, "Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01302080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*